Table 2 Characteristics of patients... | American Society of Hematology

Table 2

Characteristics of patients treated with ACT

Patient	Gender	Age	Diagnosis	Platelets (×10⁹/L)			Neutrophils (×10⁹/L)			Axial ABMvolume(ml/kg IBW)	AppendicularABM volume(ml/kg IBW)	Disease status
Patient	Gender	Age	Diagnosis	Day 30	Day 60	Day 100	Day 30	Day 60	Day 100	Axial ABMvolume(ml/kg IBW)	AppendicularABM volume(ml/kg IBW)	Disease status
1	M	50	AML	203	116	141	4.3	6	4.2	5.19	0.56	CR
2	M	55	AML	64	121	202	5.2	1.33	3.7	6.82	2.84	CR
3	M	21	NHL	122	135	143	3	2.4	4.1	6.61	2.30	SD
4	M	63	AML	141	167	180	3	2.4	5.2	4.79	5.68	SD
5	M	17	ALL	131	154	168	3.7	5.2	4.3	3.62	0.84	CR
6	M	34	ALL	255	239	289	8.6	8	6.3	4.27	10.13	CR
7	M	52	NHL	135	183	195	5.9	8	14.7	4.06	2.34	CR
8	F	52	MM	43	159	126	1.88	4.2	5.3	3.16	2.02	CR
9	M	65	ALL	127	88	28	4.1	5.46	8.5	5.52	2.68	CR
10	F	28	ALL	48	40	70	4.2	3.6	7.5	5.92	1.62	CR
11	F	60	NHL	207	250	296	3	2.9	2.7	5.98	0.15	CR
12	F	20	AML	236	209	228	5.8	4.8	3.7	6.47	0.37	PD
13	F	26	AML	65	161	194	1.9	1.9	2.8	5.91	0.53	CR
14	M	51	AML	136	103	135	0.47	5.1	3.7	3.93	0.67	CR
15	M	21	ALL	106	117	110	2.6	2.2	3.2	0.34	0.53	CR
16	M	25	NHL	58	84	161	2.6	1.3	4.1	4.61	0.89	CR
17	F	39	MM	183	244	244	1.7	1.9	2.3	3.66	2.43	CR
18	M	25	AML	127	156	181	2	2.5	4.9	5.68	1.72	CR
Mean		40 ± 17		133 ± 64	151 ± 58	172 ± 69	3.6 ± 1.9	3.8 ± 2.1	5.1 ± 2.9	4.8 ± 1.6	2.1 ± 2.4	15/18 CR
P vs CBT		NS		<.01	<.05	<.05	<.05	NS	NS	NS	<.05	NS

Patient	Gender	Age	Diagnosis	Platelets (×10⁹/L)			Neutrophils (×10⁹/L)			Axial ABMvolume(ml/kg IBW)	AppendicularABM volume(ml/kg IBW)	Disease status
Patient	Gender	Age	Diagnosis	Day 30	Day 60	Day 100	Day 30	Day 60	Day 100	Axial ABMvolume(ml/kg IBW)	AppendicularABM volume(ml/kg IBW)	Disease status
1	M	50	AML	203	116	141	4.3	6	4.2	5.19	0.56	CR
2	M	55	AML	64	121	202	5.2	1.33	3.7	6.82	2.84	CR
3	M	21	NHL	122	135	143	3	2.4	4.1	6.61	2.30	SD
4	M	63	AML	141	167	180	3	2.4	5.2	4.79	5.68	SD
5	M	17	ALL	131	154	168	3.7	5.2	4.3	3.62	0.84	CR
6	M	34	ALL	255	239	289	8.6	8	6.3	4.27	10.13	CR
7	M	52	NHL	135	183	195	5.9	8	14.7	4.06	2.34	CR
8	F	52	MM	43	159	126	1.88	4.2	5.3	3.16	2.02	CR
9	M	65	ALL	127	88	28	4.1	5.46	8.5	5.52	2.68	CR
10	F	28	ALL	48	40	70	4.2	3.6	7.5	5.92	1.62	CR
11	F	60	NHL	207	250	296	3	2.9	2.7	5.98	0.15	CR
12	F	20	AML	236	209	228	5.8	4.8	3.7	6.47	0.37	PD
13	F	26	AML	65	161	194	1.9	1.9	2.8	5.91	0.53	CR
14	M	51	AML	136	103	135	0.47	5.1	3.7	3.93	0.67	CR
15	M	21	ALL	106	117	110	2.6	2.2	3.2	0.34	0.53	CR
16	M	25	NHL	58	84	161	2.6	1.3	4.1	4.61	0.89	CR
17	F	39	MM	183	244	244	1.7	1.9	2.3	3.66	2.43	CR
18	M	25	AML	127	156	181	2	2.5	4.9	5.68	1.72	CR
Mean		40 ± 17		133 ± 64	151 ± 58	172 ± 69	3.6 ± 1.9	3.8 ± 2.1	5.1 ± 2.9	4.8 ± 1.6	2.1 ± 2.4	15/18 CR
P vs CBT		NS		<.01	<.05	<.05	<.05	NS	NS	NS	<.05	NS

PD, progressive disease; SD, stable disease.